AstraZeneca Pharma India ceased manufacturing in FY26, impacting all permanent workers.

AstraZeneca Pharma India LimitedASTRAZEN · Filed with the exchange

This shift led to substantial reductions in energy, water, GHG emissions, and waste.

The company also notably increased local sourcing from MSMEs and neighboring districts.

No comments yet. Be the first.

More from AstraZeneca Pharma India Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.